Community Counts: Exploring Transcription Regulation & Immunotherapy for ES-SCLC: Tweetorial #3 Evaluation (ID: i805-11) Survey

Question Title

* 1. How many years have you been in practice?

>21

11-20

1-10

Question Title

* 2. How many patients with ES-SCLC do you manage per week?

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 3. Please select the option that best describes your practice setting.

Academic medical center

Community medical center

VA, DOD, or other government

Managed care

Research

Pharmaceutical industry

Question Title

* 4. After participating in this activity, how confident are you in the management of patients with ES-SCLC in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 5. How frequently do you now plan to incorporate palliative care for patients with newly diagnosed SCLC?

Very frequently

Somewhat frequently

Somewhat infrequently

Very infrequently

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 7. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 8. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Increased familiarity with the efficacy and safety profiles of treatments for SCLC

Earlier implementation of palliative care

Increased utilization of palliative care resources

Increased ability to identify patients that will benefit from palliative care

Other (please specify)

Question Title

* 9. What barriers do you see to making changes in your practice? Please select all that apply. 

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating.

After participating in today’s activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Compare efficacy and safety data for new and emerging treatments for second-line extensive-stage-SCLC (ES-SCLC), as well as for immunotherapies approved in subsequent lines	Compare efficacy and safety data for new and emerging treatments for second-line extensive-stage-SCLC (ES-SCLC), as well as for immunotherapies approved in subsequent lines Strongly agree	Compare efficacy and safety data for new and emerging treatments for second-line extensive-stage-SCLC (ES-SCLC), as well as for immunotherapies approved in subsequent lines Agree	Compare efficacy and safety data for new and emerging treatments for second-line extensive-stage-SCLC (ES-SCLC), as well as for immunotherapies approved in subsequent lines Neutral	Compare efficacy and safety data for new and emerging treatments for second-line extensive-stage-SCLC (ES-SCLC), as well as for immunotherapies approved in subsequent lines Disagree	Compare efficacy and safety data for new and emerging treatments for second-line extensive-stage-SCLC (ES-SCLC), as well as for immunotherapies approved in subsequent lines Strongly disagree
Identify strategies for best supportive care to enhance quality of life in patients with relapsed or refractory ES-SCLC	Identify strategies for best supportive care to enhance quality of life in patients with relapsed or refractory ES-SCLC Strongly agree	Identify strategies for best supportive care to enhance quality of life in patients with relapsed or refractory ES-SCLC Agree	Identify strategies for best supportive care to enhance quality of life in patients with relapsed or refractory ES-SCLC Neutral	Identify strategies for best supportive care to enhance quality of life in patients with relapsed or refractory ES-SCLC Disagree	Identify strategies for best supportive care to enhance quality of life in patients with relapsed or refractory ES-SCLC Strongly disagree

Question Title

* 11. Please rate your level of agreement by checking the appropriate rating.

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Faculty for this activity was effective	Faculty for this activity was effective Strongly agree	Faculty for this activity was effective Agree	Faculty for this activity was effective Neutral	Faculty for this activity was effective Disagree	Faculty for this activity was effective Strongly disagree
Content was scientifically rigorous and evidence based	Content was scientifically rigorous and evidence based Strongly agree	Content was scientifically rigorous and evidence based Agree	Content was scientifically rigorous and evidence based Neutral	Content was scientifically rigorous and evidence based Disagree	Content was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 12. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 13. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for ES-SCLC:

Question Title

* 1. How many years have you been in practice?

Question Title

* 2. How many patients with ES-SCLC do you manage per week?

Question Title

* 3. Please select the option that best describes your practice setting.

Question Title

* 4. After participating in this activity, how confident are you in the management of patients with ES-SCLC in your practice?

Question Title

* 5. How frequently do you now plan to incorporate palliative care for patients with newly diagnosed SCLC?

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 7. Which of the following best describes the impact of this activity on your performance?

Question Title

* 8. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 9. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 10. Please rate your level of agreement by checking the appropriate rating. After participating in today’s activity, I am now better able to:

Question Title

* 11. Please rate your level of agreement by checking the appropriate rating.

Question Title

* 12. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 13. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for ES-SCLC:

Question Title

* 14. If you indicated that you perceived commercial bias or influence, please describe:

* 9. What barriers do you see to making changes in your practice? Please select all that apply. 

* 10. Please rate your level of agreement by checking the appropriate rating.

After participating in today’s activity, I am now better able to: